Vident Advisory’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$265K Buy
+17,726
New +$259K ﹤0.01% 1568
2025
Q4
Sell
-10,527
Closed -$166K 1678
2025
Q3
$166K Sell
10,527
-847
-7% -$13.9K ﹤0.01% 1575
2025
Q2
$171K Sell
11,374
-8,354
-42% -$122K ﹤0.01% 1522
2025
Q1
$297K Buy
19,728
+8,664
+78% +$128K ﹤0.01% 1272
2024
Q4
$159K Buy
11,064
+58
+0.5% +$1.04K ﹤0.01% 1373
2024
Q3
$215K Buy
+11,006
New +$199K 0.01% 1284

Other funds holding HCM

Vident Advisory's HCM Position: Q1 2026 in Review

Vident Advisory opened a new position in HUTCHMED (HCM) in Q1 2026: 17,726 shares worth $265K. The stake represents ﹤0.01% of the portfolio and ranks #1568 among its holdings. This is a return to the name: Vident Advisory previously reported a position in HCM as recently as Q3 2025.

Vident Advisory first reported a position in HCM in Q3 2024 and has held it in 6 quarters since. The position peaked at $297K in Q1 2025. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • Vident Advisory held 17,726 shares of HUTCHMED worth $265K as of Q1 2026.
  • HUTCHMED was a new Vident Advisory position in Q1 2026.
  • HUTCHMED made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1568 holding.
  • Vident Advisory first reported a position in HUTCHMED in Q3 2024 and has held it in 6 quarters since.
  • Vident Advisory's HUTCHMED position peaked at $297K in Q1 2025.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.